A
Ankit Kansagra
Researcher at University of Texas Southwestern Medical Center
Publications - 84
Citations - 1287
Ankit Kansagra is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 12, co-authored 65 publications receiving 674 citations. Previous affiliations of Ankit Kansagra include Newark Beth Israel Medical Center & North Shore Medical Center.
Papers
More filters
Journal ArticleDOI
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Ujjawal H. Gandhi,Robert F. Cornell,Arjun Lakshman,Zhubin Gahvari,Elizabeth McGehee,Megan Jagosky,Ridhi Gupta,William Varnado,Mark A. Fiala,Saurabh Chhabra,Ehsan Malek,Joshua Mansour,Barry Paul,Alyssa Barnstead,Saranya Kodali,Amarendra K. Neppalli,Michaela Liedtke,Swapna Narayana,Kelly N. Godby,Yubin Kang,Ankit Kansagra,Elvira Umyarova,Emma C. Scott,Parameswaran Hari,Ravi Vij,Saad Z. Usmani,Natalie S. Callander,Shaji Kumar,Luciano J. Costa +28 more
TL;DR: Patients with MM refractory to CD38 MoAB have poor prognosis and this study provides benchmark for new therapies to be tested in this population.
Journal ArticleDOI
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Tania Jain,Tania Jain,Merav Bar,Ankit Kansagra,Elise A. Chong,Shahrukh K. Hashmi,Shahrukh K. Hashmi,Sattva S. Neelapu,Michael Byrne,Elad Jacoby,Aleksandr Lazaryan,Caron A. Jacobson,Stephen M. Ansell,Farrukh T. Awan,Linda J. Burns,Veronika Bachanova,Catherine M. Bollard,Paul A. Carpenter,John F. DiPersio,Mehdi Hamadani,Helen E. Heslop,Joshua A. Hill,Joshua A. Hill,Krishna V. Komanduri,Craig Kovitz,Hillard M. Lazarus,Justin M. Serrette,Mohamad Mohty,David B. Miklos,Arnon Nagler,Steven Z. Pavletic,Bipin N. Savani,Stephen J. Schuster,Mohamed A. Kharfan-Dabaja,Miguel-Angel Perales,Miguel-Angel Perales,Yi Lin +36 more
TL;DR: Advice is provided from experts in the fields of hematopoietic cell transplantation, cellular immunotherapy, and lymphoma regarding key clinical questions pertinent to the utilization of CD19 CAR T for the treatment of NHL.
Journal ArticleDOI
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Ankit Kansagra,Noelle V. Frey,Merav Bar,Theodore W. Laetsch,Paul A. Carpenter,Bipin N. Savani,Helen E. Heslop,Catherine M. Bollard,Krishna V. Komanduri,Dennis A. Gastineau,Christian Chabannon,Miguel Perales,Michael Hudecek,Mahmoud Aljurf,Leslie A. Andritsos,John A. Barrett,Veronika Bachanova,Chiara Bonini,Armin Ghobadi,Saar Gill,Joshua A. Hill,Saad S. Kenderian,Partow Kebriaei,Arnon Nagler,David G. Maloney,Hien D. Liu,Nirali N. Shah,Mohamed A. Kharfan-Dabaja,Elizabeth J. Shpall,Ghulam J. Mufti,Laura Johnston,Elad Jacoby,Ali Bazarbachi,John F. DiPersio,Steven Z. Pavletic,David L. Porter,Stephan A. Grupp,Michel Sadelain,Mark R. Litzow,Mohamad Mohty,Shahrukh K. Hashmi,Shahrukh K. Hashmi +41 more
TL;DR: An initial roadmap for navigating common clinical practice scenarios that will become more prevalent now that the first commercially available CAR-T product for B-ALL has been approved is presented.
Journal ArticleDOI
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Ankit Kansagra,Noelle V. Frey,Merav Bar,Theodore W. Laetsch,Paul A. Carpenter,Bipin N. Savani,Helen E. Heslop,Catherine M. Bollard,Krishna V. Komanduri,Dennis A. Gastineau,Christian Chabannon,Miguel Perales,Michael Hudecek,Mahmoud Aljurf,Leslie A. Andritsos,John A. Barrett,Veronika Bachanova,Chiara Bonini,Armin Ghobadi,Saar Gill,Joshua A. Hill,Saad S. Kenderian,Partow Kebriaei,Arnon Nagler,David G. Maloney,Hien D. Liu,Nirali N. Shah,Mohamed A. Kharfan-Dabaja,Elizabeth J. Shpall,Ghulam J. Mufti,Laura Johnston,Elad Jacoby,Ali Bazarbachi,John F. DiPersio,Steven Z. Pavletic,David L. Porter,Stephan A. Grupp,Michel Sadelain,Mark R. Litzow,Mohamad Mohty,Shahrukh K. Hashmi +40 more
TL;DR: An initial roadmap for navigating common clinical practice scenarios that will become more prevalent now that the first commercially available CAR-T product for B-ALL has been approved is presented.
Journal ArticleDOI
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy
Zachariah DeFilipp,Anjali S. Advani,Veronika Bachanova,Ryan D. Cassaday,Daniel J. DeAngelo,Partow Kebriaei,Jacob M. Rowe,Matthew D. Seftel,Wendy Stock,Martin S. Tallman,Suzanne R. Fanning,Yoshihiro Inamoto,Ankit Kansagra,Laura Johnston,Arnon Nagler,Craig S. Sauter,Bipin N. Savani,Miguel-Angel Perales,Paul A. Carpenter,Richard A. Larson,Daniel J. Weisdorf +20 more
TL;DR: The role of hematopoietic cell transplantation for adults with acute lymphoblastic leukemia (ALL) is reviewed and critically evaluated and standard indications as well as the areas of controversy are summarized.